AAA
BHVN icon

Affinity Asset Advisors’s Biohaven BHVN Stock Holding History

Affinity Asset Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,866
Closed -$893K – 103
2023
Q4 		$893K Sell
20,866
-9,290
-31% -$289K 0.16% 69
2023
Q3 		$784K Buy
+30,156
New +$627K 0.22% 67

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Affinity Asset Advisors's BHVN Position: Q1 2024 in Review

Affinity Asset Advisors sold out of Biohaven (BHVN) in Q1 2024, closing a stake of 20,866 shares — an estimated $893K sold.

Affinity Asset Advisors first reported a position in BHVN in Q3 2023 and held it in 2 quarters. The position peaked at $893K in Q4 2023. 243 funds tracked by Wall St. Rank hold BHVN as of Q1 2024.

  • Affinity Asset Advisors reported no remaining Biohaven position as of Q1 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 20,866 Biohaven shares in Q1 2024, an estimated $893K.
  • Affinity Asset Advisors first reported a position in Biohaven in Q3 2023 and held it in 2 quarters.
  • Affinity Asset Advisors's Biohaven position peaked at $893K in Q4 2023.
  • 243 funds tracked by Wall St. Rank held Biohaven as of Q1 2024.

Based on Affinity Asset Advisors's 13F filing for Q1 2024, filed 14 May 2024.